T2 Biosystems, Inc. (TTOO)

USD 0.35

(2.88%)

Net Debt Summary of T2 Biosystems, Inc.

  • T2 Biosystems, Inc.'s latest annual net debt in 2023 was 33.8 Million USD , down -30.84% from previous year.
  • T2 Biosystems, Inc.'s latest quarterly net debt in 2024 Q2 was 14.97 Million USD , down -65.41% from previous quarter.
  • T2 Biosystems, Inc. reported annual net debt of 48.88 Million USD in 2022, up 40.06% from previous year.
  • T2 Biosystems, Inc. reported annual net debt of 34.9 Million USD in 2021, down -10.45% from previous year.
  • T2 Biosystems, Inc. reported quarterly net debt of 43.28 Million USD for 2024 Q1, up 28.04% from previous quarter.
  • T2 Biosystems, Inc. reported quarterly net debt of 33.8 Million USD for 2023 Q4, up 34.39% from previous quarter.

Annual Net Debt Chart of T2 Biosystems, Inc. (2023 - 2012)

Historical Annual Net Debt of T2 Biosystems, Inc. (2023 - 2012)

Year Net Debt Net Debt Growth
2023 33.8 Million USD -30.84%
2022 48.88 Million USD 40.06%
2021 34.9 Million USD -10.45%
2020 38.97 Million USD 15.51%
2019 33.74 Million USD 539.81%
2018 -7.67 Million USD -969.84%
2017 882 Thousand USD 102.79%
2016 -31.62 Million USD 24.03%
2015 -41.62 Million USD 21.3%
2014 -52.89 Million USD -110.4%
2013 -25.14 Million USD -556.23%
2012 -3.83 Million USD 0.0%

Peer Net Debt Comparison of T2 Biosystems, Inc.

Name Net Debt Net Debt Difference
Bionano Genomics, Inc. 34.88 Million USD 3.076%
Prenetics Global Limited -43.33 Million USD 178.014%
Star Equity Holdings, Inc. -15.33 Million USD 320.441%
CareDx, Inc -47.97 Million USD 170.471%
Exact Sciences Corporation 1.94 Billion USD 98.266%
Exagen Inc. -12.77 Million USD 364.712%
Inotiv, Inc. 382.14 Million USD 91.153%
Guardant Health, Inc. 220.22 Million USD 84.648%
Biodesix, Inc. 34.3 Million USD 1.452%
BioNexus Gene Lab Corp. -5.79 Million USD 683.322%
Precipio, Inc. -386 Thousand USD 8858.808%
iSpecimen Inc. -2.14 Million USD 1674.399%
Natera, Inc. -200.1 Million USD 116.896%
Aspira Women's Health Inc. -331 Thousand USD 10314.199%
Standard BioTools Inc. 46.5 Million USD 27.302%
23andMe Holding Co. -141.37 Million USD 123.915%
Castle Biosciences, Inc. -83.53 Million USD 140.475%
Personalis, Inc. -8.02 Million USD 521.454%
Aclaris Therapeutics, Inc. -39.45 Million USD 185.697%
Applied DNA Sciences, Inc. -5.91 Million USD 671.674%
OpGen, Inc. 11.89 Million USD -184.303%
Myriad Genetics, Inc. 88.1 Million USD 61.624%
ICON Public Limited Company 3.56 Billion USD 99.05%
NeoGenomics, Inc. 269.19 Million USD 87.441%
Star Equity Holdings, Inc. -15.33 Million USD 320.441%
IDEXX Laboratories, Inc. 493.94 Million USD 93.155%
RadNet, Inc. 1.14 Billion USD 97.056%
MDxHealth SA 18.88 Million USD -79.026%
Psychemedics Corporation 334 Thousand USD -10022.455%
Illumina, Inc. 1.21 Billion USD 97.215%
Check-Cap Ltd. -24.75 Million USD 236.569%
Twist Bioscience Corporation -192.4 Million USD 117.572%
DarioHealth Corp. -7.54 Million USD 547.92%
Fulgent Genetics, Inc. -82.56 Million USD 140.948%
Sera Prognostics, Inc. -2.02 Million USD 1772.057%
ENDRA Life Sciences Inc. -2.43 Million USD 1485.896%
OPKO Health, Inc. 230.68 Million USD 85.344%
Medpace Holdings, Inc. -103.32 Million USD 132.72%
Neogen Corporation 735.62 Million USD 95.404%
Intelligent Bio Solutions Inc. -5.43 Million USD 722.329%
Prenetics Global Limited -43.33 Million USD 178.014%
Mainz Biomed B.V. 349.85 Thousand USD -9563.718%
bioAffinity Technologies, Inc. -1.24 Million USD 2820.103%
Trinity Biotech plc 63.73 Million USD 46.955%
Neuronetics, Inc. 2.79 Million USD -1108.759%
Sotera Health Company 2.02 Billion USD 98.331%
bioAffinity Technologies, Inc. -1.24 Million USD 2820.103%